The two TET2 mutations were likely pathogenic as we identified a nonsense allele (TET2 p.Q1702*), which we validated by PCR and sequencing, and a mutation in a highly conserved residue in TET2 commonly mutated in myeloid malignancies (TET2 p.E1874K). The gene discussed is TET2; the disease is myeloid neoplasm.